Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Comtrex** is a brand name for combination over-the-counter medications formulated to provide symptomatic relief from common cold, flu, allergies, sinusitis, and related respiratory illnesses. Typical formulations include **acetaminophen** (paracetamol) as an analgesic and antipyretic for pain, headache, fever, and sore throat; a decongestant such as **pseudoephedrine** or **phenylephrine** to reduce nasal and sinus congestion; and an antihistamine like **brompheniramine** or **chlorpheniramine** to alleviate runny nose, sneezing, and itching. Some variants add **dextromethorphan** as a cough suppressant. Developed and previously marketed by companies including Novartis Consumer Health and Bristol-Myers, it is available in tablets, caplets, or liquids, primarily indicated for temporary relief of minor aches, cough, congestion, and associated symptoms without treating underlying causes.[1][2][3][4][7][8][9]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Comtrex.